Neuren Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	213.24	231.93	14.55	-	0.72	Upgrade
Other Revenue	3.59	0.02	0.86	3.2	-	Upgrade
Revenue	216.83	231.94	15.42	3.2	0.72	Upgrade
Revenue Growth (YoY)	-6.51%	1404.46%	382.23%	345.89%	44.85%	Upgrade
Cost of Revenue	32.97	26.75	12.71	9.52	7.76	Upgrade
Gross Profit	183.86	205.19	2.71	-6.32	-7.05	Upgrade
Selling, General & Admin	4.7	5.95	3.44	1.91	1.76	Upgrade
Operating Expenses	4.7	5.95	3.44	1.91	1.76	Upgrade
Operating Income	179.16	199.25	-0.73	-8.23	-8.81	Upgrade
Interest & Investment Income	11.01	5.69	0.39	0.04	0.15	Upgrade
Currency Exchange Gain (Loss)	-7.24	2.43	1.23	0.4	-0.63	Upgrade
Other Non Operating Income (Expenses)	-	-2.23	-0.7	-	0.1	Upgrade
EBT Excluding Unusual Items	182.94	205.14	0.18	-7.79	-9.19	Upgrade
Pretax Income	182.94	205.14	0.18	-7.79	-9.19	Upgrade
Income Tax Expense	40.9	48.06	-	-	-	Upgrade
Earnings From Continuing Operations	142.04	157.08	0.18	-7.79	-9.19	Upgrade
Net Income	142.04	157.08	0.18	-7.79	-9.19	Upgrade
Net Income to Common	142.04	157.08	0.18	-7.79	-9.19	Upgrade
Net Income Growth	-9.57%	85270.11%	-	-	-	Upgrade
Shares Outstanding (Basic)	128	127	126	118	107	Upgrade
Shares Outstanding (Diluted)	131	131	129	119	107	Upgrade
Shares Change (YoY)	0.01%	1.44%	8.76%	10.71%	6.88%	Upgrade
EPS (Basic)	1.11	1.24	0.00	-0.07	-0.09	Upgrade
EPS (Diluted)	1.09	1.20	0.00	-0.07	-0.09	Upgrade
EPS Growth	-9.58%	120020.00%	-	-	-	Upgrade
Free Cash Flow	-11.28	184.89	3.58	-9.98	-8.08	Upgrade
Free Cash Flow Per Share	-0.09	1.41	0.03	-0.08	-0.08	Upgrade
Gross Margin	84.80%	88.47%	17.55%	-197.65%	-	Upgrade
Operating Margin	82.63%	85.90%	-4.75%	-257.52%	-1228.59%	Upgrade
Profit Margin	65.51%	67.72%	1.19%	-243.79%	-1282.15%	Upgrade
Free Cash Flow Margin	-5.20%	79.71%	23.22%	-312.17%	-1127.48%	Upgrade
EBITDA	179.18	199.26	-0.72	-8.23	-8.8	Upgrade
EBITDA Margin	82.64%	85.91%	-4.68%	-257.27%	-	Upgrade
D&A For EBITDA	0.02	0.02	0.01	0.01	0.01	Upgrade
EBIT	179.16	199.25	-0.73	-8.23	-8.81	Upgrade
EBIT Margin	82.63%	85.90%	-4.75%	-257.52%	-	Upgrade
Effective Tax Rate	22.36%	23.43%	-	-	-	Upgrade
Revenue as Reported	227.85	240.06	17.03	3.64	0.96	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.